FOLD - Amicus Therapeutics, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue91,24536,9304,958-
Cost of Revenue14,4046,236833-
Gross Profit76,84130,6944,125-
Operating Expenses
Research Development163,902141,210104,79374,343
Selling General and Administrative234,20088,27171,15149,869
Non Recurring----
Others----
Total Operating Expenses416,722239,310180,019126,045
Operating Income or Loss-325,477-202,380-175,061-126,045
Income from Continuing Operations
Total Other Income/Expenses Net-23,612-246,741-28,720-6,073
Earnings Before Interest and Taxes-325,477-202,380-175,061-126,045
Interest Expense-22,402-17,240-5,398-1,578
Income Before Tax-349,089-449,121-203,781-132,118
Income Tax Expense-94-165,119-3,739-
Minority Interest----
Net Income From Continuing Ops-348,995-284,002-200,042-132,118
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-348,995-284,002-200,042-132,118
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-348,995-284,002-200,042-132,118